The  @oncoAlert  Round Up
September 1- 7, 2023
REGISTER TO GET IT at  http://OncoAlert360.com 

Discussing: 

@fda Breakthrough therapy designations for Trastuzumab deruxtecan
Sequencing Endocrine & Targeted Txin Hormone sensitive HER2- #breastcancer
Neoadj palbociclib+giredestrant or anastrozole in ER+, HER2- early breast #cancer
Exercise& Nutritionon Chemo Completion & pCR in Breast #Cancer
Bladder-Sparing Treatment w/ Radical Dose RT Is Effective Alternative to Radical Cystectomy in Node+ Nonmets and more...